Development and Validation of a Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis: PREDICT-HP
Rochester, MN
The purpose of this study is to establish and validate testing for disease progression in peripheral mononuclear cells (PMBC) from patients with Chronic Hypersensitivity Pneumonitis (CHP) at initial presentation, and to validate blood tests over time to predict disease progression.